BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR

BrickBio, the leader in RNA facilitated site-specific conjugation for novel protein therapeutics, will be presenting an invited poster at the annual meeting of the American Association of Cancer Research (AACR) Conference on April 11th, 2022 during the Antibody-Drug Conjugates Session. BrickBio will be located at Booth #3334 throughout the conference.